<DOC>
	<DOCNO>NCT00276107</DOCNO>
	<brief_summary>To determine immunogenicity Prevenar infant immunize 2 , 4 6 month age . To determine antibody response seven pneumococcal vaccine serotypes one month second dose determine safety Prevenar infant immunize 2,4 6 month age .</brief_summary>
	<brief_title>Study Evaluating Prevenar Vaccine Healthy Infants</brief_title>
	<detailed_description />
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Healthy male female child 2 month age ( 42 100 day ) good health . An informed consent must sign parent legal guardian follow detailed explanation participation study . Infants whose parent ( ) /guardian ( ) available entire study period . Hypersensitivity component vaccine , include diphtheria toxoid Infants thrombocytopenia coagulation disorder would contraindicate intramuscular injection Infants know suspected impairment immunologic function include HIV receive immunosuppressive therapy . Other exclusion apply .</criteria>
	<gender>All</gender>
	<minimum_age>42 Days</minimum_age>
	<maximum_age>100 Days</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Vaccine</keyword>
	<keyword>Healthy Infants</keyword>
</DOC>